Multiple missense mutations in the diazepam binding inhibitor (DBI) gene identified in schizophrenia but lack of disease association.
about
Schizophrenia proteomics: biomarkers on the path to laboratory medicine?Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.The audacity of proteomics: a chance to overcome current challenges in schizophrenia research.Phosphotyrosine profiling of human cerebrospinal fluid
P2860
Multiple missense mutations in the diazepam binding inhibitor (DBI) gene identified in schizophrenia but lack of disease association.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multiple missense mutations in ...... t lack of disease association.
@en
type
label
Multiple missense mutations in ...... t lack of disease association.
@en
prefLabel
Multiple missense mutations in ...... t lack of disease association.
@en
P2093
P356
P1476
Multiple missense mutations in ...... t lack of disease association.
@en
P2093
P2860
P356
10.1002/AJMG.B.20102
P577
2004-02-01T00:00:00Z